EMAIL THIS PAGE TO A FRIEND

American journal of respiratory and critical care medicine

Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.


PMID 25073001

Abstract

Effective therapeutic interventions for chronic, idiopathic lung diseases remain elusive. Normalized T-cell function is an important contributor to spontaneous resolution of pulmonary sarcoidosis. Up-regulation of inhibitor receptors, such as programmed death-1 (PD-1) and its ligand, PD-L1, are important inhibitors of T-cell function. To determine the effects of PD-1 pathway blockade on sarcoidosis CD4(+) T-cell proliferative capacity. Gene expression profiles of sarcoidosis and healthy control peripheral blood mononuclear cells were analyzed at baseline and follow-up. Flow cytometry was used to measure ex vivo expression of PD-1 and PD-L1 on systemic and bronchoalveolar lavage-derived cells of subjects with sarcoidosis and control subjects, as well as the effects of PD-1 pathway blockade on cellular proliferation after T-cell receptor stimulation. Immunohistochemistry analysis for PD-1/PD-L1 expression was conducted on sarcoidosis, malignant, and healthy control lung specimens. Microarray analysis demonstrates longitudinal increase in PDCD1 gene expression in sarcoidosis peripheral blood mononuclear cells. Immunohistochemistry analysis revealed increased PD-L1 expression within sarcoidosis granulomas and lung malignancy, but this was absent in healthy lungs. Increased numbers of sarcoidosis PD-1(+) CD4(+) T cells are present systemically, compared with healthy control subjects (P < 0.0001). Lymphocytes with reduced proliferative capacity exhibited increased proliferation with PD-1 pathway blockade. Longitudinal analysis of subjects with sarcoidosis revealed reduced PD-1(+) CD4(+) T cells with spontaneous clinical resolution but not with disease progression. Analogous to the effects in other chronic lung diseases, these findings demonstrate that the PD-1 pathway is an important contributor to sarcoidosis CD4(+) T-cell proliferative capacity and clinical outcome. Blockade of the PD-1 pathway may be a viable therapeutic target to optimize clinical outcomes.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C3241 Anti-CCR-7 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB4300627
Anti-CCR7 antibody produced in rabbit, affinity isolated antibody
SAB4500329
Anti-CCR7 antibody produced in rabbit, affinity isolated antibody
SAB3501089
Anti-CCR7 antibody produced in rabbit, affinity isolated antibody
SAB4300654
Anti-CD11c antibody produced in rabbit, affinity isolated antibody
GW23003 Anti-CD19 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
PRS4065
Anti-PD-1 (ab1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
PRS4067
Anti-PD-1 (ab2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900280
Anti-PDCD1 (AB1) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2900373
Anti-PDCD1 (AB2) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2500763
Anti-PDCD1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1400196
Anti-PDCD1 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
HPA035981
Anti-PDCD1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA013411 Anti-PDCD1LG2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1411458
Anti-PDCD1LG2 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB4700390 Monoclonal Anti-CD11c antibody produced in mouse, clone BU15, purified immunoglobulin, buffered aqueous solution
WH0000930M1
Monoclonal Anti-CD19 antibody produced in mouse, clone 1G3, purified immunoglobulin, buffered aqueous solution
SAB1403645
Monoclonal Anti-CD19 antibody produced in mouse, clone 1C9, purified immunoglobulin, buffered aqueous solution
SAB4700108 Monoclonal Anti-CD19 antibody produced in mouse, clone 4G7, purified immunoglobulin, buffered aqueous solution
SAB4700109 Monoclonal Anti-CD19 antibody produced in mouse, clone LT19, purified immunoglobulin, buffered aqueous solution
SAB3500122
Monoclonal Anti-PD-1 antibody produced in mouse, clone 7A11B1, purified immunoglobulin, buffered aqueous solution
SAB3500123
Monoclonal Anti-PD-1 antibody produced in mouse, clone 12A7D7, purified immunoglobulin, buffered aqueous solution